Evidence map›Paper›PMID 35887148›Full record

ReviewInternational journal of molecular sciences2022

Ketamine plus Alcohol: What We Know and What We Can Expect about This.

Natalia Harumi Correa Kobayashi, Sarah Viana Farias, Diandra Araújo Luz, Kissila Márvia Machado-Ferraro, Brenda Costa da Conceição, Cinthia Cristina Menezes da Silveira, Luanna Melo Pereira Fernandes, Sabrina de Carvalho Cartágenes, Vânia Maria Moraes Ferreira, Enéas Andrade Fontes-Júnior and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Gas necrosis and sepsis due to recreational ketamine use.Revista do Instituto de Medicina Tropical de Sao Paulo · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Natalia Harumi Correa KobayashiLaboratory of Pharmacology of Inflammation and Behavior, Faculty of Pharmacy, Institute of Health Science, Federal University of Pará, Belém 66075110, PA, Brazil.
Sarah Viana FariasLaboratory of Pharmacology of Inflammation and Behavior, Faculty of Pharmacy, Institute of Health Science, Federal University of Pará, Belém 66075110, PA, Brazil.
Diandra Araújo LuzLaboratory of Pharmacology of Inflammation and Behavior, Faculty of Pharmacy, Institute of Health Science, Federal University of Pará, Belém 66075110, PA, Brazil.ORCID 0000-0002-9703-2062
Kissila Márvia Machado-FerraroLaboratory of Pharmacology of Inflammation and Behavior, Faculty of Pharmacy, Institute of Health Science, Federal University of Pará, Belém 66075110, PA, Brazil.
Brenda Costa da ConceiçãoLaboratory of Pharmacology of Inflammation and Behavior, Faculty of Pharmacy, Institute of Health Science, Federal University of Pará, Belém 66075110, PA, Brazil.
Cinthia Cristina Menezes da SilveiraLaboratory of Pharmacology of Inflammation and Behavior, Faculty of Pharmacy, Institute of Health Science, Federal University of Pará, Belém 66075110, PA, Brazil.
Luanna Melo Pereira FernandesLaboratory of Pharmacology of Inflammation and Behavior, Faculty of Pharmacy, Institute of Health Science, Federal University of Pará, Belém 66075110, PA, Brazil.ORCID 0000-0001-7004-0719
Sabrina de Carvalho CartágenesLaboratory of Pharmacology of Inflammation and Behavior, Faculty of Pharmacy, Institute of Health Science, Federal University of Pará, Belém 66075110, PA, Brazil.
Vânia Maria Moraes FerreiraLaboratory of Psychobiology, Psychology Institute, University of Brasília, Campus Universitário Darcy Ribeiro-Asa Norte, Brasília 70910900, DF, Brazil.
Enéas Andrade Fontes-JúniorLaboratory of Pharmacology of Inflammation and Behavior, Faculty of Pharmacy, Institute of Health Science, Federal University of Pará, Belém 66075110, PA, Brazil.ORCID 0000-0002-6186-9581
Cristiane do Socorro Ferraz MaiaLaboratory of Pharmacology of Inflammation and Behavior, Faculty of Pharmacy, Institute of Health Science, Federal University of Pará, Belém 66075110, PA, Brazil.ORCID 0000-0003-4493-7375
Universidade Federal do Pará · BRUniversidade de Brasília · BR

Funding

Federal University of Para Edital 02/2022 - PAPQ/PROPESPNational Council for Scientific and Technological Development 311335/2019-5
6 · The paper itself

Abstract

Drug abuse has become a public health concern. The misuse of ketamine, a psychedelic substance, has increased worldwide. In addition, the co-abuse with alcohol is frequently identified among misusers. Considering that ketamine and alcohol share several pharmacological targets, we hypothesize that the consumption of both psychoactive substances may synergically intensify the toxicological consequences, both under the effect of drugs available in body systems and during withdrawal. The aim of this review is to examine the toxicological mechanisms related to ketamine plus ethanol co-abuse, as well the consequences on cardiorespiratory, digestive, urinary, and central nervous systems. Furthermore, we provide a comprehensive discussion about the probable sites of shared molecular mechanisms that may elicit additional hazardous effects. Finally, we highlight the gaps of knowledge in this area, which deserves further research.

Indexed as

KetamineSubstance-Related DisordersEthanolHumansEthanolKetamineaddictionalcoholcardiorespiratory systemcentral nervous systemdigestive systemdrug abuseketaminerenal systemtoxicological effects

Identifiers

PMID35887148
PMCPMC9323326
OpenAlexW4285592961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.